Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hypoglycemia

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hypoglycemia in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, Y1
Matsuwaki, T1
Yamanouchi, K1
Nishihara, M1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hypoglycemia

ArticleYear
Cyclooxygenase-2-related signaling in the hypothalamus plays differential roles in response to various acute stresses.
    Brain research, 2013, May-01, Volume: 1508

    Topics: Adrenalectomy; Animals; Corticotropin-Releasing Hormone; Cyclooxygenase 2; Cyclooxygenase 2 Inhibito

2013